Abstract:Background: Lipoprotein-associated phospholipase A2 activity (Lp-PLA2-A) is a pivotal enzyme involved in the inflammatory process and atherosclerotic plaque vulnerability. This study aimed to investigate the potential of Lp-PLA2-A as a biomarker for reflecting artery-to-artery embolism (AAE), a critical mechanism with high risk of stroke recurrence in symptomatic intracranial atherosclerotic disease (sICAD). Methods: The current analysis included a cohort of 1,908 patients with sICAD and baseline levels of Lp-PLA2-A from the Third China National Stroke Registry (CNSR-III). The baseline Lp-PLA2-A levels were quantified centrally using an automatic enzyme assay system. Diagnosis of sICAD was made by experienced stroke neurologists based on the presence of a cerebral infarction within the territory of a stenotic (>50 %) or occluded artery, or when clinical symptoms were consistent with the diagnosis. Infarct lesions affecting the cortex serve as imaging biomarkers for stroke mechanism involving AAE.The relationship between baseline Lp-PLA2-A quartile levels and the presence of cortical infarction was analyzed using multivariate logistic regression. Results: Compared to patients in the first Lp-PLA2-A quartile, those in the second, third and fourth quartiles demonstrated a significantly higher proportion of AAE. The proportion of patients with cortical infarction increased with rising Lp-PLA2-A quartiles, observed at 39.3 %, 47.1 %, 47.4 %, and 50.7 % for the first, second, third and fourth quartiles respectively (P for trend=0.004). Compared with the first quartile, the odds ratios (ORs) were 1.38 (95 % CI = 1.06-1.79) for the second, 1.33 (95 % CI = 1.02-1.72) for the third quartile and 1.48 (95 % CI = 1.14-1.92) for the fourth quartile. The association between higher Lp-PLA2-A and increased proportion of cortical infarction was also present in the subgroups defined by age <65 years, male, and high-sensitivity C-reactive protein ≥2 mg/L. In sensitivity analyses, the positive correlation between Lp-PLA2-A levels and proportion of cortical infarction remained consistent. Conclusions: This research highlights the significance of Lp-PLA2-A as a biomarker for reflecting stroke mechanism in sICAD. Additional studies are warranted to explore the potential of targeting Lp-PLA2-associated inflammatory pathways as a pivotal approach in arresting the advancement of intracranial atherosclerotic stenosis and reducing the incidence of embolic strokes.

Circulating secretory type IIA phospholipase A2, lipoprotein (a) and soluble cellular adhesion molecule levels in patients with angina pectoris.

Relationship of Secretory Type Ⅱ Phospholipase A2, Coronary Artery Score and Atherogenic Index in Patients with Coronary Artery Disease

The Changes of Secretory Type Ⅱ Phospholipase A2 in Coronary Heart Disease and Its Relationship with High Sensifive-C Reactive Protein

Association Between Plasma Lysophosphatidic Acid and Coronary Stenosis with Coronary Heart Disease

Association of lipoprotein-associated phospholipase A 2 with characteristics of vulnerable coronary atherosclerotic plaques

Correlation between lipoprotein-associated phospholipase A2 and main risk factors in unstable angina pectoris patients

[Elevated Serum Secretory Type II Phospholipase A2 in Patients with Coronary Heart Disease].

The clinical significance of sCD40L and Lp-PLA2 in the assessment of coronary artery severity and risk classification in patients with non-ST-segment elevation acute coronary syndrome

Value of serum lipoprotein(a) measurement in patients with acute coronary syndrome

The Correlation Between Lipoprotein-Associated Phospholipase A2 and Severity of Coronary Artery Diseases

Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study

Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina: An inverse link to lipoprotein(a)

Elevated Plasma Lipoprotein-Associated Phospholipase A(2) Activity is Associated with Plaque Rupture in Patients with Coronary Artery Disease

Elevated Levels of Platelet-Monocyte Aggregates and Related Circulating Biomarkers in Patients with Acute Coronary Syndrome.

Relationship Between Cytokines and Angina Pectoris and Its Risk Factors

Relationship Between Coronary Atherosclerotic Plaque and Secretory Type Ⅱ Phospholipase A2,Hypersensitive C-Reactive Protein

Lipoprotein-Associated Phospholipase A 2 Activity Level May Be Complementary to Cardiactroponin I As a Biomarker for Acute Myocardial Infarction in Chinese Patients with Chest Pain

[A Correlation Study of Serum Inflammatory Factors and Intravascular Ultrasound Features of Atherosclerotic Plaques in Patients with Angina Pectoris].

Lipoprotein-associated phospholipase A2 activity levels is associated with artery to artery embolism in symptomatic intracranial atherosclerotic disease

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease

Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages